Reviews Prezista


No reviews yet.

Prezista Drug Description
PREZISTA
(darunavir) Tablet, Film Coated for Oral use
DRUG DESCRIPTION



What are the possible side effects of darunavir (Prezista)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking darunavir and call your doctor at once if you have any of these serious side effects:

fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
the first sign of any skin rash, no matter how mild;
increased urination or extreme thirst;
signs of a new infection,...
Read All Potential Side Effects for Prezista »




PREZISTA (darunavir) is an inhibitor of the human immunodeficiency virus (HIV) protease.
PREZISTA (darunavir), in the form of darunavir ethanolate, has the following
chemical name: [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic
acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl
ester monoethanolate. Its molecular formula is C27H37N3O7S
• C2H5OH and its molecular weight is 593.73. Darunavir
ethanolate has the following structural formula:








Darunavir ethanolate is a white to off-white powder with a solubility of approximately 0.15 mg/mL in water at 20°C.
PREZISTA 75 mg tablets are available as white, caplet-shaped, film-coated tablets for oral administration. PREZISTA 150 mg tablets are available as white, oval-shaped, film-coated tablets for oral administration. PREZISTA 300 mg and PREZISTA 600 mg tablets are available as orange, oval-shaped, film-coated tablets for oral administration. PREZISTA 400 mg is available as a light orange, oval-shaped, film-coated tablet for oral administration.
Each 75 mg tablet contains darunavir ethanolate equivalent to 75 mg of darunavir. Each 150 mg tablet contains darunavir ethanolate equivalent to 150 mg of darunavir. Each 300 mg tablet contains darunavir ethanolate equivalent to 300 mg of darunavir. Each 400 mg tablet contains darunavir ethanolate equivalent to 400 mg of darunavir. Each 600 mg tablet contains darunavir ethanolate equivalent to 600 mg of darunavir. During storage, partial conversion from ethanolate to hydrate may occur; however, this does not affect product quality or performance. Each tablet also contains the inactive ingredients colloidal silicon dioxide, crospovidone, magnesium stearate, and microcrystalline cellulose. The tablet film coating, OPADRY® White, contains polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide. The tablet film coating, OPADRY® Orange, contains FD&C Yellow No. 6, polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide.
All dosages for PREZISTA are expressed in terms of the free form of darunavir.
Last reviewed on RxList: 5/24/2010




Prezista Drug Description
PREZISTA
(darunavir) Tablet, Film Coated for Oral use
DRUG DESCRIPTION



What are the possible side effects of darunavir (Prezista)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking darunavir and call your doctor at once if you have any of these serious side effects:

fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
the first sign of any skin rash, no matter how mild;
increased urination or extreme thirst;
signs of a new infection,...
Read All Potential Side Effects for Prezista »




PREZISTA (darunavir) is an inhibitor of the human immunodeficiency virus (HIV) protease.
PREZISTA (darunavir), in the form of darunavir ethanolate, has the following
chemical name: [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic
acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl
ester monoethanolate. Its molecular formula is C27H37N3O7S
• C2H5OH and its molecular weight is 593.73. Darunavir
ethanolate has the following structural formula:








Darunavir ethanolate is a white to off-white powder with a solubility of approximately 0.15 mg/mL in water at 20°C.
PREZISTA 75 mg tablets are available as white, caplet-shaped, film-coated tablets for oral administration. PREZISTA 150 mg tablets are available as white, oval-shaped, film-coated tablets for oral administration. PREZISTA 300 mg and PREZISTA 600 mg tablets are available as orange, oval-shaped, film-coated tablets for oral administration. PREZISTA 400 mg is available as a light orange, oval-shaped, film-coated tablet for oral administration.
Each 75 mg tablet contains darunavir ethanolate equivalent to 75 mg of darunavir. Each 150 mg tablet contains darunavir ethanolate equivalent to 150 mg of darunavir. Each 300 mg tablet contains darunavir ethanolate equivalent to 300 mg of darunavir. Each 400 mg tablet contains darunavir ethanolate equivalent to 400 mg of darunavir. Each 600 mg tablet contains darunavir ethanolate equivalent to 600 mg of darunavir. During storage, partial conversion from ethanolate to hydrate may occur; however, this does not affect product quality or performance. Each tablet also contains the inactive ingredients colloidal silicon dioxide, crospovidone, magnesium stearate, and microcrystalline cellulose. The tablet film coating, OPADRY® White, contains polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide. The tablet film coating, OPADRY® Orange, contains FD&C Yellow No. 6, polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide.
All dosages for PREZISTA are expressed in terms of the free form of darunavir.
Last reviewed on RxList: 5/24/2010




Prezista Drug Description
PREZISTA
(darunavir) Tablet, Film Coated for Oral use
DRUG DESCRIPTION



What are the possible side effects of darunavir (Prezista)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking darunavir and call your doctor at once if you have any of these serious side effects:

fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
the first sign of any skin rash, no matter how mild;
increased urination or extreme thirst;
signs of a new infection,...
Read All Potential Side Effects for Prezista »




PREZISTA (darunavir) is an inhibitor of the human immunodeficiency virus (HIV) protease.
PREZISTA (darunavir), in the form of darunavir ethanolate, has the following
chemical name: [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic
acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl
ester monoethanolate. Its molecular formula is C27H37N3O7S
• C2H5OH and its molecular weight is 593.73. Darunavir
ethanolate has the following structural formula:








Darunavir ethanolate is a white to off-white powder with a solubility of approximately 0.15 mg/mL in water at 20°C.
PREZISTA 75 mg tablets are available as white, caplet-shaped, film-coated tablets for oral administration. PREZISTA 150 mg tablets are available as white, oval-shaped, film-coated tablets for oral administration. PREZISTA 300 mg and PREZISTA 600 mg tablets are available as orange, oval-shaped, film-coated tablets for oral administration. PREZISTA 400 mg is available as a light orange, oval-shaped, film-coated tablet for oral administration.
Each 75 mg tablet contains darunavir ethanolate equivalent to 75 mg of darunavir. Each 150 mg tablet contains darunavir ethanolate equivalent to 150 mg of darunavir. Each 300 mg tablet contains darunavir ethanolate equivalent to 300 mg of darunavir. Each 400 mg tablet contains darunavir ethanolate equivalent to 400 mg of darunavir. Each 600 mg tablet contains darunavir ethanolate equivalent to 600 mg of darunavir. During storage, partial conversion from ethanolate to hydrate may occur; however, this does not affect product quality or performance. Each tablet also contains the inactive ingredients colloidal silicon dioxide, crospovidone, magnesium stearate, and microcrystalline cellulose. The tablet film coating, OPADRY® White, contains polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide. The tablet film coating, OPADRY® Orange, contains FD&C Yellow No. 6, polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide.
All dosages for PREZISTA are expressed in terms of the free form of darunavir.
Last reviewed on RxList: 5/24/2010




Prezista Drug Description
PREZISTA
(darunavir) Tablet, Film Coated for Oral use
DRUG DESCRIPTION



What are the possible side effects of darunavir (Prezista)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking darunavir and call your doctor at once if you have any of these serious side effects:

fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
the first sign of any skin rash, no matter how mild;
increased urination or extreme thirst;
signs of a new infection,...
Read All Potential Side Effects for Prezista »




PREZISTA (darunavir) is an inhibitor of the human immunodeficiency virus (HIV) protease.
PREZISTA (darunavir), in the form of darunavir ethanolate, has the following
chemical name: [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic
acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl
ester monoethanolate. Its molecular formula is C27H37N3O7S
• C2H5OH and its molecular weight is 593.73. Darunavir
ethanolate has the following structural formula:








Darunavir ethanolate is a white to off-white powder with a solubility of approximately 0.15 mg/mL in water at 20°C.
PREZISTA 75 mg tablets are available as white, caplet-shaped, film-coated tablets for oral administration. PREZISTA 150 mg tablets are available as white, oval-shaped, film-coated tablets for oral administration. PREZISTA 300 mg and PREZISTA 600 mg tablets are available as orange, oval-shaped, film-coated tablets for oral administration. PREZISTA 400 mg is available as a light orange, oval-shaped, film-coated tablet for oral administration.
Each 75 mg tablet contains darunavir ethanolate equivalent to 75 mg of darunavir. Each 150 mg tablet contains darunavir ethanolate equivalent to 150 mg of darunavir. Each 300 mg tablet contains darunavir ethanolate equivalent to 300 mg of darunavir. Each 400 mg tablet contains darunavir ethanolate equivalent to 400 mg of darunavir. Each 600 mg tablet contains darunavir ethanolate equivalent to 600 mg of darunavir. During storage, partial conversion from ethanolate to hydrate may occur; however, this does not affect product quality or performance. Each tablet also contains the inactive ingredients colloidal silicon dioxide, crospovidone, magnesium stearate, and microcrystalline cellulose. The tablet film coating, OPADRY® White, contains polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide. The tablet film coating, OPADRY® Orange, contains FD&C Yellow No. 6, polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide.
All dosages for PREZISTA are expressed in terms of the free form of darunavir.
Last reviewed on RxList: 5/24/2010




Prezista Drug Description
PREZISTA
(darunavir) Tablet, Film Coated for Oral use
DRUG DESCRIPTION



What are the possible side effects of darunavir (Prezista)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking darunavir and call your doctor at once if you have any of these serious side effects:

fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
the first sign of any skin rash, no matter how mild;
increased urination or extreme thirst;
signs of a new infection,...
Read All Potential Side Effects for Prezista »




PREZISTA (darunavir) is an inhibitor of the human immunodeficiency virus (HIV) protease.
PREZISTA (darunavir), in the form of darunavir ethanolate, has the following
chemical name: [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic
acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl
ester monoethanolate. Its molecular formula is C27H37N3O7S
• C2H5OH and its molecular weight is 593.73. Darunavir
ethanolate has the following structural formula:








Darunavir ethanolate is a white to off-white powder with a solubility of approximately 0.15 mg/mL in water at 20°C.
PREZISTA 75 mg tablets are available as white, caplet-shaped, film-coated tablets for oral administration. PREZISTA 150 mg tablets are available as white, oval-shaped, film-coated tablets for oral administration. PREZISTA 300 mg and PREZISTA 600 mg tablets are available as orange, oval-shaped, film-coated tablets for oral administration. PREZISTA 400 mg is available as a light orange, oval-shaped, film-coated tablet for oral administration.
Each 75 mg tablet contains darunavir ethanolate equivalent to 75 mg of darunavir. Each 150 mg tablet contains darunavir ethanolate equivalent to 150 mg of darunavir. Each 300 mg tablet contains darunavir ethanolate equivalent to 300 mg of darunavir. Each 400 mg tablet contains darunavir ethanolate equivalent to 400 mg of darunavir. Each 600 mg tablet contains darunavir ethanolate equivalent to 600 mg of darunavir. During storage, partial conversion from ethanolate to hydrate may occur; however, this does not affect product quality or performance. Each tablet also contains the inactive ingredients colloidal silicon dioxide, crospovidone, magnesium stearate, and microcrystalline cellulose. The tablet film coating, OPADRY® White, contains polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide. The tablet film coating, OPADRY® Orange, contains FD&C Yellow No. 6, polyethylene glycol 3350, polyvinyl alcohol-partially hydrolyzed, talc, and titanium dioxide.
All dosages for PREZISTA are expressed in terms of the free form of darunavir.
Last reviewed on RxList: 5/24/2010





Other reviews about Prezista on wordpress

TMC 125 (Etravirine) and TMC 114 (Prezista)
  by jeremiahandrews
This article comes from BC PWA news letter. I publish this article because I will be taking these meds starting next week. (TMC114 - Prezista-Darunavir and TMC125 […]


Medical Update 11-21-07
  by jeremiahandrews
Everyone is freaking CRAZY! Holy Shit, first they send me TWO god damned virgins for triage and I am like, WTF!! After waiting almost an hour in an […]


Pharma News 3_17
  by Steve Woodruff
Pharma Sales reps - what rewards do they most prefer? Pharma Sales reps - gift-giving ban in Massachusetts coming? Plus, a summary from Med Ad News on the growing […]


Updates to Prezista (Darunavir) Tablets Labeling
  by morganwrites
(TBP) - Updates have been made to Prezista (darunavir) tablets labeling to reflect significant new risk information. Changes have been made to the CLINICAL PHARMACOLOGY section to include […]


Once-Daily Prezista(R) (Darunavir) For Treatment-Naïve Adults With HIV-1 Receives EU Approval As Part Of Combination Therapy
  by enartion
Tibotec Pharmaceuticals announced that the European Commission approved once-daily dosing of 800 mg PREZISTA® (darunavir), a protease inhibitor, with low-dose ritonavir as part of combination therapy in treatment-naïve […]


PREZISTA(R) Now Available For Pediatric Patients Six Years Of Age And Older As Part Of HIV Combination Therapy
  by enartion
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced the availability of a lower-dose (75 mg) formulation of PREZISTA (darunavir) for pediatric patients with HIV. The […]


Day 47 - New Meds
  by hivblogger
Well it happened on Day 43, I got new medication from the consultant. Basicaly the diarrhoea and tiredness were getting too much and so the Kaletra has been […]


June 23
  by hivblogger
St Etheldreda's Day [caption id="" align="alignright" width="165" caption="St Etheldreda, Abbess of Ely, pray for us."][/caption] Today is St Etheldreda's Day. The day that the Church remembers a holy Abbess in […]


HIV/AIDS Update -Expanded indication for Selzentry (maraviroc)
  by neurologist
On November 20, 2009, the Food and Drug Administration approved a supplemental NDA to expand the indication for Selzenttry (maraviroc) to include combination antiretroviral treatment of therapy naïve […]


HIV/AIDS Update - Prezista (darunavir) labeling changes reflect 96 week study data
  by neurologist
On January 27, 2010, FDA approved revisions to the Prezista (darunavir) product labeling to include the 96 week data from two trials; one trial in treatment-experienced patients (TMC114-C214) and one […]



Other reviews about Prezista on web:

What is the most important information I should know about PREZISTA ®? PREZISTA ®, together with Norvir ® , has rarely been observed to cause liver problems which may be life ... Patients-Caregivers home | Prezista


The third party trademark used here in are trademarks of their respective owners © Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P. 2010. Home Page | Prezista


Prezista (darunavir) used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Includes Prezista side effects, interactions and indications. Prezista Information from Drugs.com


Complete info about Prezista (darunavir), a protease inhibitor ... Prezista belongs to a class of anti-HIV drugs called Protease Inhibitors (PIs). AIDSmeds.com - Prezista


Learn about the prescription medication Prezista (Darunavir), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Prezista (Darunavir) Drug Information: Uses, Side Effects, Drug ...


All about Prezista. View complete and up to date Prezista information - part of the Drugs.com trusted medication database. Prezista Facts and Comparisons at Drugs.com


Darunavir (brand name Prezista, formerly known as TMC114) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option ... Darunavir - Wikipedia, the free encyclopedia


Prezista, a trademark for darunavir. darunavir ethanolate. Prezista. Pharmacologic class: Protease inhibitor. Therapeutic class: Antiretroviral. Pregnancy risk category B Prezista - definition of Prezista in the Medical dictionary - by ...


Prezista is a medicine commonly used as part of an HIV "cocktail" for the treatment of HIV and AIDS. This eMedTV segment explains what you should know before taking this ... Prezista


Prezista is an HIV protease inhibitor used for treating HIV infection in certain patients along with other antiretroviral medicines. Side effects and interactions are available at ... Prezista - drugstore.com. Low prices, side effects, interactions.





Featured Reviews

Reviews Ethionamide Tablets

Trecator Drug Description Trecator® (ethionamide, USP) Tablets DRUG DESCRIPTION What are the possible side effects of ethionamide (Trecator-SC)? If you experience any of the following serious side effects, stop taking ethionamide...
Read More  |  Review This
Reviews Imogam Rabies

Imogam Rabies Drug Description Imogam® Rabies HT Rabies Immune Globulin (human), USP DRUG DESCRIPTION What are the possible side effects of rabies vaccine (Imovax Rabies (obsolete), Imovax Rabies I.D. (obsolete), RabAvert...
Read More  |  Review This
Reviews Xylocaine

Xylocaine Drug Description Xylocaine® (lidocaine HCl) Injection, USP Xylocaine® (lidocaine HCl and epinephrine) Injection, USP For Infiltration and Nerve Block DRUG DESCRIPTION Xylocaine (lidocaine HCl) Injections are sterile,...
Read More  |  Review This
Reviews Amaryl

Amaryl Drug Description AMARYL® (glimepiride) Tablets 1, 2, and 4 mg DRUG DESCRIPTION What are the possible side effects of glimepiride (Amaryl)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Lioresal Intrathecal

Lioresal Intrathecal Drug Description LIORESAL® INTRATHECAL (baclofen) Injection Abrupt discontinuation of intrathecal baclofen, regardless of the cause, has resulted in sequelae that include high fever, altered mental status,...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....